NEPHROS INC

NEPH Nasdaq CIK: 0001196298

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 380 LACKAWANNA PLACE, SOUTH ORANGE, NJ, 07079
Mailing Address 380 LACKAWANNA PLACE, SOUTH ORANGE, NJ, 07079
Phone 201.343.5202
Fiscal Year End 1231
EIN 133971809

Recent SEC Filings

Form Type Date Filed Document
8-K Current report of material events March 27, 2026 View on SEC
4 Insider stock transaction report March 25, 2026 View on SEC
4 Insider stock transaction report March 25, 2026 View on SEC
4 Insider stock transaction report March 18, 2026 View on SEC
4 Insider stock transaction report March 18, 2026 View on SEC
10-K Annual financial report March 12, 2026 View on SEC
8-K Current report of material events November 26, 2025 View on SEC
SCHEDULE 13G Passive beneficial ownership (>5%) November 14, 2025 View on SEC
4 Insider stock transaction report November 13, 2025 View on SEC
4 Insider stock transaction report November 13, 2025 View on SEC

Annual Reports

10-K March 12, 2026
  • Strong demand for medical infection control filters significantly boosted revenue.
  • Successful launch of commercial PFAS reduction solution positions Nephros in a growing market.
View Analysis

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.